Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Shire interim CFO to step down

Country: Ireland

James Bowling, the interim chief financial officer of Shire Plc, has decided to step down from his position effective 31 March 2015. He is to join Severn Trent Plc as CFO. Shire said that it will start recruitment for a new CFO immediately.

Read more

Roche has flat nine-month sales

Country: Switzerland

The Roche group reported sales of CHF 34.8 billion (€28.8 billion) for the first nine months of 2014, unchanged from a year earlier. At constant exchange rates sales increased by 5%. The main event of the period was its acquisition of InterMune Inc for $8.3 billion in the third quarter.

Read more

Genomics England lists candidate suppliers

Country: United Kingdom

Read more

Shire share price falls further as AbbVie formally rejects its bid

Country: United Kingdom

Read more

Shire says it prefers to merge with Abbvie

Country: United Kingdom

Read more

Rigontec’s novel cancer treatment gets funding

Country: Germany

Read more

Nextech raises $40 million in first closing of its fourth fund

Country: Switzerland

Read more

FDA approves combination therapy for HCV

Country: United States

Read more

Oxford BioMedica extends collaboration with Novartis

Country: United Kingdom

Read more

Magnus Life Science launched in UK

Country: United Kingdom

Read more

Seed funding for UK oncology company

Country: United Kingdom

Read more

Departure of Novartis executives

Country: Switzerland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Commentary- A greater patient voice in drug development by Richard Pops

CommentaryRichardPopsOct2014.pdf

Highlights of the October 2014 MedNous issue

The October 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    Why European biopharma
    is starved for capital
  • Oncology Review
    New agents fight
    B-cell malignancies
  • Commentary
    Collaboration to deliver
    superior value to patients
    by Roch Doliveux
  • Commentary
    A greater patient voice in drug development
    By Richard Pops
  • Regulatory
    EMA to make clinical data public
  • Regulatory
    Nobel Prize awarded for brain research

The latest MedNous journal. Subscribe to download.

Recent Appointments